Lilly-NUS participate in all clinical pharmacology aspects of drug development, but with an emphasis on exploring interethnic pharmacology questions in man.
The research pipeline from Eli Lilly provides candidate drugs in six main therapeutic areas:
• Endocrine Disorders
• Infectious Diseases
• Cardiovascular Diseases
• Gene regulation, bone, and inflammation